DE69715883D1 - Stabilisierung von interferonen in wässriger lösung durch gummiarabikum - Google Patents

Stabilisierung von interferonen in wässriger lösung durch gummiarabikum

Info

Publication number
DE69715883D1
DE69715883D1 DE69715883T DE69715883T DE69715883D1 DE 69715883 D1 DE69715883 D1 DE 69715883D1 DE 69715883 T DE69715883 T DE 69715883T DE 69715883 T DE69715883 T DE 69715883T DE 69715883 D1 DE69715883 D1 DE 69715883D1
Authority
DE
Germany
Prior art keywords
interferones
lab
stabilization
rubber
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69715883T
Other languages
English (en)
Other versions
DE69715883T2 (de
Inventor
Peter R Rothschild
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FERONPATENT Ltd
Original Assignee
FERONPATENT Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FERONPATENT Ltd filed Critical FERONPATENT Ltd
Publication of DE69715883D1 publication Critical patent/DE69715883D1/de
Application granted granted Critical
Publication of DE69715883T2 publication Critical patent/DE69715883T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69715883T 1996-05-09 1997-05-09 Stabilisierung von interferonen in wässriger lösung durch gummiarabikum Expired - Fee Related DE69715883T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB9600433 1996-05-09
PCT/IB1997/000531 WO1997041885A1 (en) 1996-05-09 1997-05-09 Stabilization of interferons in aqueous solution for manufacture of sublingually administered tablets

Publications (2)

Publication Number Publication Date
DE69715883D1 true DE69715883D1 (de) 2002-10-31
DE69715883T2 DE69715883T2 (de) 2003-07-31

Family

ID=11004429

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69715883T Expired - Fee Related DE69715883T2 (de) 1996-05-09 1997-05-09 Stabilisierung von interferonen in wässriger lösung durch gummiarabikum

Country Status (8)

Country Link
EP (1) EP0920329B1 (de)
AP (1) AP1168A (de)
AT (1) ATE224725T1 (de)
AU (1) AU2401197A (de)
DE (1) DE69715883T2 (de)
DK (1) DK0920329T3 (de)
ES (1) ES2184084T3 (de)
WO (1) WO1997041885A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997041885A1 (en) * 1996-05-09 1997-11-13 Feronpatent Limited Stabilization of interferons in aqueous solution for manufacture of sublingually administered tablets
JP2001526662A (ja) * 1997-05-09 2001-12-18 フェロンパテント リミテッド 舌下投与式タブレットの製造のための水溶液におけるインターフェロンの安定化
US6391296B1 (en) 1997-08-01 2002-05-21 Toray Industries, Inc. Method of stabilizing useful protein and useful protein compositions
FR2836379B1 (fr) * 2002-02-28 2007-06-01 Dit Bon Michel Betend Formes galeniques solides de medicaments homeopathiques, dont les allergenes ou antigenes, en dilutions homeopathiques pour preparation extemporanee pour un seul individu pour administration sublinguale
JP2008501639A (ja) * 2004-04-23 2008-01-24 ノベシン リミテッド タンパク質を安定化、保護及び可溶化させるための方法及びキット
EP1749018B1 (de) * 2004-04-23 2014-10-22 Expedeon Limited Verfahren und kits zur stabilisierung, zum schutz und zur solubilisierung von proteinen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH156609A (de) * 1931-01-27 1932-08-15 Chem Pharm Lab Bika V Poehlman Verfahren zur Herstellung eines trockenen, homöopathischen Heilmittels.
EP0123291A2 (de) * 1983-04-20 1984-10-31 Kyowa Hakko Kogyo Co., Ltd. Verfahren zur Stabilisierung von Interferon
DE3484374D1 (de) * 1983-08-04 1991-05-08 Green Cross Corp Gamma-interferonzusammensetzung.
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
FR2619714B1 (fr) * 1987-09-02 1991-07-12 Medibrevex Nouvelles formes galeniques de theophylline pour administration par voie per- et sublinguale
CA2024046A1 (en) * 1989-09-28 1991-03-29 Alberto Ferro Stabilized leukocyte-interferons
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
WO1997041885A1 (en) * 1996-05-09 1997-11-13 Feronpatent Limited Stabilization of interferons in aqueous solution for manufacture of sublingually administered tablets

Also Published As

Publication number Publication date
AP9901682A0 (en) 1999-12-31
ATE224725T1 (de) 2002-10-15
ES2184084T3 (es) 2003-04-01
AP1168A (en) 2003-06-30
EP0920329B1 (de) 2002-09-25
AU2401197A (en) 1997-11-26
EP0920329A1 (de) 1999-06-09
WO1997041885A1 (en) 1997-11-13
DK0920329T3 (da) 2003-01-27
DE69715883T2 (de) 2003-07-31

Similar Documents

Publication Publication Date Title
BR9810801B1 (pt) composição lìquida aquosa.
DE69700813T2 (de) Verwendung von stabilen aminofunktionellen latexen in wässrigen tinten
ATE272313T1 (de) Ein oder mehrere schädlingsbekämpfungsmittel enthaltendes emulsionskonzentrat
DE60002696D1 (de) Redundanzbeseitigung in der persistenz von objektgraphen
DE69518454D1 (de) Abschätzung von Anregungsparametern
DE69801676D1 (de) Wässrige emulsionen von fischer-tropschparaffinen
DE69530210T2 (de) Durch detergentien geförderte immunotests von pharmakologischen wirkstoffen
DE69512702D1 (de) Wässrige Tintezusammensetzung
DE69822366D1 (de) Wässrige Emulsionszusammensetzung
ATE440086T1 (de) Kontrolle von arthropoden in tieren
DE69715883T2 (de) Stabilisierung von interferonen in wässriger lösung durch gummiarabikum
DE60006799D1 (de) Oralverabreichbare lösung von prucaloprid
DE59406332D1 (de) Niedrigviskose wässrige konzentrate von betaintensiden
DE59603739D1 (de) Flüssigkonfektionierung von verdickungsmitteln (ii)
DE69609600D1 (de) Verbesserte chemilumineszente lösung
DE69500167D1 (de) Wässrige Lösung zur Oberflächenbehandlung von Metallen
DE69500605T2 (de) Wässrige Primerzusammensetzung
DE69729746D1 (de) Hochstabile wässrige lösung von teilverseiftem vinylesterharz
DE69917623D1 (de) Ophthalmologische lösung enthaltend glykogen
DE69515179T2 (de) Bauelement zur errichtung von strukturen
DE69602155D1 (de) Verbesserung von Branntweinen
DE69604890T2 (de) Flüssige zusammensetzung zur stabilisierung von bypiridinium-herbiziden
ATE325194T1 (de) Antithrombinnukleotide und -proteine von haematobia irritans
DE59504988D1 (de) Niedrigviskose wässrige konzentrate von betaintensiden
DE69716598T2 (de) Stabilisierung von anstrichen durch spiroindanderivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee